Search

everythinglearnresearchcommunity

for

Search:↓

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Skin lymphatic vessels are essential for hair growth.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Non-immune factors play a significant role in alopecia areata.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Eating vitamin A affects hair growth and health by changing cell signals in mice.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Using methods like lasers and microneedling with drugs can improve hair regrowth for alopecia, but more research is needed on safety and best practices.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Some alopecia treatments might help treat COVID-19, but more research is needed.

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

CD2 might be a new treatment target for patchy alopecia areata.

Hair loss treatment caused more hair loss in a man.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Some alternative medicine treatments might work for skin conditions, but their effectiveness and safety differ a lot.

People with rheumatoid arthritis have a higher risk of developing alopecia areata.

OCT can detect hidden hair follicles in alopecia areata, indicating potential hair regrowth.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.